Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunodeficiency-associated lymphoproliferative disorders.

D M Knowles1

  • 1Department of Pathology, Cornell University Medical College, New York, New York, USA.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|March 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.

Leukemia·2015
Same author

Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma.

Blood cancer journal·2014
Same author

Inactivation of BANK1 in a novel IGH-associated translocation t(4;14)(q24;q32) suggests a tumor suppressor role in B-cell lymphoma.

Blood cancer journal·2014
Same author

Clonal X-chromosome inactivation suggests that splenic cord capillary hemangioma is a true neoplasm and not a subtype of splenic hamartoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2010
Same author

Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).

Histopathology·2008
Same author

Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib.

Leukemia·2008
Same journal

Expanding the Spectrum of High-Risk Human Papilloma Virus (HPV)-Associated Glandular Neoplasms of the Anorectum.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same journal

Deep Learning for Differentiating Pulmonary Metastasis from Primary Lung Cancer Constructed on Frozen Sections for Intraoperative Diagnosis.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same journal

Margin Adequacy in Phyllodes Tumours Revisited: Reappraisal of the Evidence Base and Knowledge Gaps.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same journal

Genomic Characterization of Classic Adamantinoma, Osteofibrous Dysplasia, and Osteofibrous Dysplasia-like Adamantinoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same journal

Immunophenotypic, Cytogenetic, and Molecular Characterization of NUP98-Rearranged Pediatric Myeloid Neoplasms.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same journal

Chromoanagenesis in Myelodysplastic Syndromes Is Associated With Highly Complex Karyotype, TP53 Disruption and Dismal Prognosis.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
See all related articles

Immunodeficiency increases lymphoproliferative disease risk, presenting heterogeneous disorders often linked to Epstein-Barr virus (EBV). Diagnosis requires correlating clinical, histopathologic, and molecular features for effective management.

Area of Science:

  • Immunopathology
  • Oncology
  • Virology

Background:

  • Immunodeficiency, whether congenital, acquired, or iatrogenic, significantly elevates the risk of lymphoproliferative diseases.
  • These disorders are clinically and pathologically diverse, varying in clonal composition and association with specific immunodeficiency syndromes.

Purpose of the Study:

  • To review the heterogeneous nature of immunodeficiency-associated lymphoproliferative disorders.
  • To highlight diagnostic challenges and the importance of correlative analysis for accurate classification and management.
  • To underscore their role as a model for studying lymphoid neoplasia development.

Main Methods:

  • Review of existing literature and studies on lymphoproliferative disorders in immunodeficient individuals.

Related Experiment Videos

  • Analysis of histopathologic, immunophenotypic, clonal, viral, and genetic characteristics.
  • Categorization of post-transplantation and AIDS-related lymphoproliferative disorders.

    • Main Results:

    • Shared features include extranodal involvement, aggressive histology, B-cell origin, Epstein-Barr virus (EBV) association, and rapid progression.
    • Post-transplantation disorders range from polyclonal plasmacytic hyperplasias to monoclonal lymphomas, with polymorphic types showing variable behavior linked to bcl-6 mutations.
    • AIDS-related lymphomas are predominantly monoclonal B-cell neoplasms, with distinct subtypes based on site and histology, some associated with Kaposi's sarcoma-associated herpesvirus.

    Conclusions:

    • Immunodeficiency-associated lymphoproliferative disorders pose diagnostic challenges, necessitating integrated analysis of clinical and laboratory data.
    • Accurate diagnosis relies on correlating patient presentation with histopathology, immunophenotype, clonality, viral status, and genetic alterations.
    • These conditions serve as valuable models for understanding lymphoid neoplasia pathogenesis.